Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
BackgroundFinerenone has been shown to improve outcomes in patients with heart failure (HF), encompassing those with reduced (HFrEF), mildly reduced (HFmrEF), or preserved ejection fraction (HFpEF). However, its clinical use is accompanied by notable adverse effects. This study aimed to evaluate the...
Shranjeno v:
| Principais autores: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2025-05-01
|
| Serija: | Frontiers in Cardiovascular Medicine |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1601552/full |
| Oznake: |
Brez oznak, prvi označite!
|